Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Exjade labeling receives new Warning and Adverse Reactions information

May 28, 2007

Nalmefene licensing agreement enters into force

May 25, 2007

AEOL-10150 to be studied in mustard gas-mediated lung injury

May 25, 2007

Novartis in-licenses CYT002-NicQb for treatment of nicotine addiction

April 26, 2007

Vivitrol filed for approval in U.K. and Germany

April 5, 2007

Nicotine patch appears safe for use in coronary artery disease patients

April 4, 2007

Exjade filed in Japan

April 3, 2007

Positive preclinical profile of the CRF1 antagonist MTIP in animal models of alcoholism

March 27, 2007

EVT-302 for smoking cessation begins clinical testing

March 26, 2007

Cleveland BioLabs to submit Protectan CBLB-502 in response to RFP

March 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...